![The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006322319313794-gr1.jpg)
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
![Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.npp.1300251/MediaObjects/41386_2003_Article_BF1300251_Fig1_HTML.gif)
Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology
![The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40261-021-01032-7/MediaObjects/40261_2021_1032_Fig1_HTML.png)
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation
![Buprenorphine | Tool for Palliative Care Clinicians | Palliative in Practice | Center to Advance Palliative Care Buprenorphine | Tool for Palliative Care Clinicians | Palliative in Practice | Center to Advance Palliative Care](https://media.capc.org/images/Buprenorphine_pharmacology_700x282-revised.original.png)
Buprenorphine | Tool for Palliative Care Clinicians | Palliative in Practice | Center to Advance Palliative Care
![JCM | Free Full-Text | Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder JCM | Free Full-Text | Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder](https://www.mdpi.com/jcm/jcm-10-03727/article_deploy/html/images/jcm-10-03727-g001-550.jpg)
JCM | Free Full-Text | Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Anesthesia & Analgesia - Analgesic Effect of Buprenorphine for Chronic Noncancer Pain: A #SystematicReview and Meta-analysis of Randomized Controlled Trials https://buff.ly/44MBhUQ KEY POINTS 💊 Question: What is the analgesic efficacy and safety
![A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig2_HTML.png)
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
![A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig4_HTML.png)
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
![Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors | Journal of Neuroscience Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/23/32/10331/F6.large.jpg)
Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors | Journal of Neuroscience
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
![Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-B978012420118700010X-f10-01-9780124201187.jpg)
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
![Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization | Journal of Neuroscience Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/29/22/7341/F1.large.jpg)